問卷
此案目前為暫存狀態
編修至YYYY/MM/DD
不開放編輯功能
Find Division/Department
National Taiwan University Hospital
All Location
All Division/Department
篩選
Developmental Phase
Phase I
Phase I/II
Phase II
Phase II/III
Phase III
Phase IV
Others
Trial Status
Not yet recruiting
Active
Completed
Recruitment Status
Recruiting
Terminated
Stop recruiting
Suspended
Study ended
Trial scale
Multi-Regional Multi-Center
Taiwan Multiple Center
Taiwan Single Center
The expected start time interval of the test
Trial Applicant
Hospital/Foundation
Pharmaceutical/Biopharmaceutical company
Contract Research Organization
Important Roles
Asia Regional PI
Taiwan National PI
Chairman/Global PI
Steering Committee
Advisory board
None
Audit by Sponsors/CRO
Sponsors
CRO
Investigator-initiated trial(IIT)
Yes
Filters
下載
2012-02-01 - 2014-12-31
Condition/Disease
Test Drug
Participate Sites8Sites
Terminated8Sites
2011-08-30 - 2014-07-30
Participate Sites17Sites
Terminated17Sites
2010-08-30 - 2012-11-30
Atrial Fibrillation
MK-6621
Participate Sites16Sites
Terminated16Sites
2010-11-01 - 2012-12-31
Participate Sites4Sites
Terminated4Sites
2011-04-01 - 2014-04-30
2008-06-15 - 2010-12-30
Participate Sites3Sites
Terminated3Sites
2010-03-01 - 2012-12-31
2009-07-01 - 2012-12-31
2011-07-08 - 2013-06-30
2018-08-31 - 2026-05-31
Triple-Negative Breast Cancer
Atezolizumab (RO5541267)
Participate Sites13Sites
Not yet recruiting3Sites
Recruiting1Sites
Terminated9Sites
Division of General Surgery
全部
